NewAmsterdam Pharma Company (NasdaqGM:NAMS) FY 2025 Conference December 03, 2025 03:15 PM ET Speaker0Yeah, the Global Healthcare Conference at Citi. My name's Jeff Meacham. I am the head of healthcare, global head of biotech, pharma research. Fun, fun. We're thrilled today to have NewAmsterdam Pharma. So we have Michael Davidson, CEO. We have Ian Somaiya, CFO. Guys, thanks a lot for the time.Speaker1Thanks, Jia.Speaker0So maybe we'll just do a quick background, Michael. You want to give a couple-minute pitc ...

公司药物试验结果 - 公司备受期待的阿尔茨海默病试验最终未获成功 [1] 公司核心产品 - 公司是重磅药物Ozempic和Wegovy的制造商 [1] 行业科学探讨 - 科学家仍在探讨GLP-1类药物是否具有其他潜在应用 [1]